These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3731072)
1. Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro. Wassermann K; Zwelling LA; Mullins TD; Silberman LE; Andersson BS; Bakic M; Acton EM; Newman RA Cancer Res; 1986 Aug; 46(8):4041-6. PubMed ID: 3731072 [TBL] [Abstract][Full Text] [Related]
2. Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin. Lau DH; Ross KL; Sikic BI Cancer Res; 1990 Jul; 50(13):4056-60. PubMed ID: 2162251 [TBL] [Abstract][Full Text] [Related]
3. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro. Begleiter A; Leith MK; Johnston JB Cancer Res; 1994 Jan; 54(2):482-6. PubMed ID: 8275485 [TBL] [Abstract][Full Text] [Related]
4. Effect of morpholinyladriamycin analogs and adriamycin on the activities of DNA polymerase alpha and RNA polymerase II of chicken leukemia cells. Chuang LF; Chuang RY; Acton EM; Israel M; Yu M J Pharmacol Exp Ther; 1987 Jul; 242(1):372-7. PubMed ID: 2441029 [TBL] [Abstract][Full Text] [Related]
5. Doxorubicin and the alkylating anthracycline 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin: comparative in vitro potency against leukemia and bone marrow cells. Beckman RA; McFall PJ; Sikic BI; Smith SD J Natl Cancer Inst; 1988 May; 80(5):361-5. PubMed ID: 3357201 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Ling YH; Priebe W; Perez-Soler R Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504 [TBL] [Abstract][Full Text] [Related]
7. Effects of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells. Jesson MI; Johnston JB; Anhalt CD; Begleiter A Cancer Res; 1987 Nov; 47(22):5935-8. PubMed ID: 3664494 [TBL] [Abstract][Full Text] [Related]
8. Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues. Duran GE; Lau DH; Lewis AD; Kühl JS; Bämmler TK; Sikic BI Cancer Chemother Pharmacol; 1996; 38(3):210-6. PubMed ID: 8646794 [TBL] [Abstract][Full Text] [Related]
9. Toxicity of 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin and doxorubicin in nude mice bearing human tumour xenografts. Ford CH; Richardson VJ; Pushpanathan C; Ali SK Anticancer Res; 1991; 11(5):1855-62. PubMed ID: 1768056 [TBL] [Abstract][Full Text] [Related]
10. Can cytotoxic activity of anthracyclines be related to DNA damage? Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin. Jesson MI; Johnston JB; Robotham E; Begleiter A Cancer Res; 1989 Dec; 49(24 Pt 1):7031-6. PubMed ID: 2531036 [TBL] [Abstract][Full Text] [Related]
12. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630 [TBL] [Abstract][Full Text] [Related]
13. DNA cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells. Scudder SA; Brown JM; Sikic BI J Natl Cancer Inst; 1988 Oct; 80(16):1294-8. PubMed ID: 3172256 [TBL] [Abstract][Full Text] [Related]
14. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells. Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645 [TBL] [Abstract][Full Text] [Related]
15. Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin. Lau DH; Durán GE; Sikic BI J Natl Cancer Inst; 1992 Oct; 84(20):1587-92. PubMed ID: 1404452 [TBL] [Abstract][Full Text] [Related]
16. Association of DNA cross-linking with potentiation of the morpholino derivative of doxorubicin by human liver microsomes. Lau DH; Lewis AD; Sikic BI J Natl Cancer Inst; 1989 Jul; 81(13):1034-8. PubMed ID: 2733045 [TBL] [Abstract][Full Text] [Related]
17. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells. Capranico G; Soranzo C; Zunino F Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414 [TBL] [Abstract][Full Text] [Related]
18. N-(5,5-diacetoxypentyl)doxorubicin: a novel anthracycline producing DNA interstrand cross-linking and rapid endonucleolytic cleavage in human leukemia cells. Zwelling LA; Altschuler E; Cherif A; Farquhar D Cancer Res; 1991 Dec; 51(24):6704-7. PubMed ID: 1660346 [TBL] [Abstract][Full Text] [Related]
19. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells. Streeter DG; Johl JS; Gordon GR; Peters JH Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Ling YH; el-Naggar AK; Priebe W; Perez-Soler R Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]